Zhu B - Search Results

1

Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials.

Kimball AB, Luger T, Gottlieb A, Puig L, Kaufmann R, Nikaï E, Zhu B, Edson-Heredia E, Carlier H, Lin CY, Goldblum O, Yosipovitch G. Kimball AB, et al. Among authors: zhu b. J Am Acad Dermatol. 2016 Dec;75(6):1156-1161. doi: 10.1016/j.jaad.2016.07.034. Epub 2016 Sep 27. J Am Acad Dermatol. 2016. PMID: 27692498 Clinical Trial.

2

Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study.

Zhu B, Edson-Heredia E, Gatz JL, Guo J, Shuler CL. Zhu B, et al. Clin Ther. 2013 Sep;35(9):1376-85. doi: 10.1016/j.clinthera.2013.07.328. Epub 2013 Aug 15. Clin Ther. 2013. PMID: 23954091

3

Early clinical response as a predictor of subsequent response to ixekizumab treatment: results from a phase II study of patients with moderate-to-severe plaque psoriasis.

Zhu B, Edson-Heredia E, Cameron GS, Shen W, Erickson J, Shrom D, Wang P, Banerjee S, Gordon KB. Zhu B, et al. Br J Dermatol. 2013 Dec;169(6):1337-41. doi: 10.1111/bjd.12610. Br J Dermatol. 2013. PMID: 24032554 Clinical Trial.

4

Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial.

Zhu B, Edson-Heredia E, Guo J, Maeda-Chubachi T, Shen W, Kimball AB. Zhu B, et al. Br J Dermatol. 2014 Nov;171(5):1215-9. doi: 10.1111/bjd.13065. Epub 2014 Oct 15. Br J Dermatol. 2014. PMID: 24749812 Clinical Trial.

5

Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink.

Edson-Heredia E, Zhu B, Lefevre C, Wang M, Barrett A, Bushe CJ, Cox A, Wu JJ, Maeda-Chubachi T. Edson-Heredia E, et al. Among authors: zhu b. J Eur Acad Dermatol Venereol. 2015 May;29(5):955-63. doi: 10.1111/jdv.12742. Epub 2014 Oct 28. J Eur Acad Dermatol Venereol. 2015. PMID: 25352213

6

Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis.

Langley RG, Rich P, Menter A, Krueger G, Goldblum O, Dutronc Y, Zhu B, Wei H, Cameron GS, Heffernan MP. Langley RG, et al. Among authors: zhu b. J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1763-70. doi: 10.1111/jdv.12996. Epub 2015 Feb 18. J Eur Acad Dermatol Venereol. 2015. PMID: 25693783 Clinical Trial.

7

A high level of clinical response is associated with improved patient-reported outcomes in psoriasis: analyses from a phase 2 study in patients treated with ixekizumab.

Edson-Heredia E, Banerjee S, Zhu B, Maeda-Chubachi T, Cameron GS, Shen W, Heffernan MP, Gordon KB, Leonardi CL. Edson-Heredia E, et al. Among authors: zhu b. J Eur Acad Dermatol Venereol. 2016 May;30(5):864-5. doi: 10.1111/jdv.13032. Epub 2015 Mar 13. J Eur Acad Dermatol Venereol. 2016. PMID: 25773781 Clinical Trial. No abstract available.

8

Disease burden and quality of life in psoriasis patients with and without comorbid psoriatic arthritis: results from National Psoriasis Foundation panel surveys.

Edson-Heredia E, Zhu B, Guo J, Maeda-Chubachi T, Lebwohl M. Edson-Heredia E, et al. Among authors: zhu b. Cutis. 2015 Mar;95(3):173-8. Cutis. 2015. PMID: 25844782

9

Understanding the Relationship Between Pruritus Severity and Work Productivity in Patients With Moderate-to-Severe Psoriasis: Sleep Problems Are a Mediating Factor.

Kimball AB, Edson-Heredia E, Zhu B, Guo J, Maeda-Chubachi T, Shen W, Bianchi MT. Kimball AB, et al. Among authors: zhu b. J Drugs Dermatol. 2016 Feb;15(2):183-8. J Drugs Dermatol. 2016. PMID: 26885786 Clinical Trial.

10

Effect of Ixekizumab Treatment on Work Productivity for Patients With Moderate-to-Severe Plaque Psoriasis: Analysis of Results From 3 Randomized Phase 3 Clinical Trials.

Armstrong AW, Lynde CW, McBride SR, Ståhle M, Edson-Heredia E, Zhu B, Amato D, Nikaï E, Yang FE, Gordon KB. Armstrong AW, et al. Among authors: zhu b. JAMA Dermatol. 2016 Jun 1;152(6):661-9. doi: 10.1001/jamadermatol.2016.0269. JAMA Dermatol. 2016. PMID: 26953848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,312 results

Search Page

Filters